Dentists in Lake Ozark, MO Accepting Medicare
3 Dentists found. Showing 1 - 3
 Dr. Robert Earl Carroll, GENERAL DENTIST Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 2935 Bagnell Dam Blvd Ste 102, Lake Ozark, MO 65049 Phone: 573-365-6600 Fax: 573-365-6470 |
Ronald Eric Massie, DDS, FAGD Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 24 North Shore Dr, Lake Ozark, MO 65026 Phone: 573-365-0220 Fax: 573-365-1962 |
Mark Roy Bagby, DDS Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 2935 Bagnell Dam Blvd Ste 112, Lake Ozark, MO 65049 Phone: 578-349-9578 |
News Archive
Roche receives FDA approval for CMV viral load test
The U.S. Food and Drug Administration today approved the first DNA test to help health care professionals gauge the progress of anti-viral treatment in solid organ transplant patients undergoing cytomegalovirus (CMV) antiviral therapy.
Keystone meeting focuses on neuroinflammation, Alzheimer's and other neurodegenerative diseases
As Alzheimer's disease sweeps through the brain, do the brain's immune cells sit idly by and let it happen? Or could they overreact and make the disease worse?
Accountable Care Organizations trigger legal worries from health care providers and insurers
Kaiser Health News staff writers Jenny Gold and Phil Galewitz report: "Doctors and hospitals eager to pursue a new model of health care being promoted by the Obama administration are raising concerns that they could run afoul of antitrust and anti-fraud laws, while insurers are warning that the new arrangements could lead to higher prices for medical care" (Gold and Galewitz, 10/5).
BSD MTX-180 MicroThermX Microwave Ablation System receives CE Mark approval
BSD Medical Corporation, the company that pioneered heat therapy applications, today reported that the Company has received CE Mark approval for the commercial sale of The MicroThermX Microwave Ablation System (MTX-180) in Europe. CE marking approval allows BSD to market the MTX-180 in the 30 countries that comprise the European Union (EU) and the European Free Trade Association (EFTA).
Amneal Pharmaceuticals receives FDA approval for Spironolactone HCl tablets
Amneal Pharmaceuticals, LLC is pleased to announce that it has received U.S. FDA approval to manufacture Spironolactone HCl tablets in 25 mg, 50 mg and 100 mg strengths effective July 2, 2010.
› Verified 3 days ago
Counselors
Clinical Social Workers
Dentists
Occupational Therapists
Psychologists
Pharmacists